How a scientific slip-up caused a pregnant woman to get an untested treatment

Taking stock of the drug industry, from the lab to the medicine chest

April 22, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

José A. Alvarado Jr. for STAT STAT+ | How a scientific slip-up caused a pregnant woman to get an untested treatment for preterm birth To prevent preterm birth, some pregnant women were mistakenly given progesterone instead of 17P, a nomenclature mixup now 20 years old. By Annalisa Merelli STAT+ | In a scientific first, researchers use CRISPR base editing to treat liver disease in fetal monkeys The ambitious idea of using CRISPR to cure genetic diseases before birth is one step closer to reality, new research shows. By Megan Molteni Opinion: An FDA pathway can accelerate innovation for Duchenne muscular dystrophy Few treatments are available for people with Duchenne muscular dystrophy. The FDA's accelerated approval program can help change that. By Jennifer Handt

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser